Cargando…

LIFESPAN NEURODEGENERATION OF THE HUMAN BRAIN IN MULTIPLE SCLEROSIS

BACKGROUND: Atrophy related to Multiple Sclerosis (MS) has been found at the early stages of the disease. However, the archetype dynamic trajectories of the neurodegenerative process, even prior to clinical diagnosis, remain unknown. METHODS: We modeled the volumetric trajectories of brain structure...

Descripción completa

Detalles Bibliográficos
Autores principales: Coupé, Pierrick, Planche, Vincent, Mansencal, Boris, Kamroui, Reda A., Koubiyr, Ismail, Manjon, José V., Tourdias, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055083/
https://www.ncbi.nlm.nih.gov/pubmed/36993352
http://dx.doi.org/10.1101/2023.03.14.532535
Descripción
Sumario:BACKGROUND: Atrophy related to Multiple Sclerosis (MS) has been found at the early stages of the disease. However, the archetype dynamic trajectories of the neurodegenerative process, even prior to clinical diagnosis, remain unknown. METHODS: We modeled the volumetric trajectories of brain structures across the entire lifespan using 40944 subjects (38295 healthy controls and 2649 MS patients). Then, we estimated the chronological progression of MS by assessing the divergence of lifespan trajectories between normal brain charts and MS brain charts. RESULTS: Chronologically, the first affected structure was the thalamus, then the putamen and the pallidum (3 years later), followed by the ventral diencephalon (7 years after thalamus) and finally the brainstem (9 years after thalamus). To a lesser extent, the anterior cingulate gyrus, insular cortex, occipital pole, caudate and hippocampus were impacted. Finally, the precuneus and accumbens nuclei exhibited a limited atrophy pattern. CONCLUSION: Subcortical atrophy was more pronounced than cortical atrophy. The thalamus was the most impacted structure with a very early divergence in life. It paves the way toward utilization of these lifespan models for future preclinical/prodromal prognosis and monitoring of MS.